Market closed

Ovid Therapeutics/$OVID

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Ovid Therapeutics

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

Ticker

$OVID
Sector
Health Care
Trading on
NASDAQ

Industry

Biotechnology
Headquarters
New York, United States

Employees

25
Website
www.ovidrx.com

OVID Metrics

BasicAdvanced
$57M
-
-$0.46
0.29
-

$57M

0.29

$4.10

$0.68

331K

5.66

5.392

18.039

19.76

-36.04%

-36.60%

90.145

0.75

0.75

-0.981

113.21%

-33.30%

-85.66%

-37.00%

What the Analysts think about OVID

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Ovid Therapeutics stock.

OVID Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

OVID Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $OVID

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Ovid Therapeutics stock?

Ovid Therapeutics (OVID) has a market cap of $57M as of January 15, 2025.

What is the P/E ratio for Ovid Therapeutics stock?

The price to earnings (P/E) ratio for Ovid Therapeutics (OVID) stock is 0 as of January 15, 2025.

Does Ovid Therapeutics stock pay dividends?

No, Ovid Therapeutics (OVID) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Ovid Therapeutics dividend payment date?

Ovid Therapeutics (OVID) stock does not pay dividends to its shareholders.

What is the beta indicator for Ovid Therapeutics?

Ovid Therapeutics (OVID) has a beta rating of 0.29. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.